Retrospective hospital-based analysis of age-related macular degeneration patterns in India: 5-year follow-up

被引:4
|
作者
Sudhalkar, Aditya [1 ]
Sethi, Vaibhav [2 ]
Gogte, Priyanka [2 ]
Bondalapati, Sailaja [4 ]
Khodani, Mitali [2 ]
Chhablani, Jay Kumar [3 ]
机构
[1] Eye Hosp & Retina Ctr, Vadodara, Gujarat, India
[2] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Dis, Hyderabad, Telangana, India
[3] LV Prasad Eye Inst, Smt Kanuri Santhamma Retina Vitreous Ctr, Kallam Anji Reddy Campus,Banjara Hills, Hyderabad 500034, Telangana, India
[4] Univ N Carolina, Sch Med, Smt Kannuri Santhamma Ctr Vitreoretinal Dis, Chapel Hill, NC USA
关键词
Age-related macular degeneration; anti-vascular endothelial growth factor therapy; hospital-based analysis; India; BLUE MOUNTAINS EYE; RISK-FACTORS; MACULOPATHY LESIONS; POPULATION; PREVALENCE; RANIBIZUMAB; PROGRESSION; DISEASE; SYSTEM;
D O I
10.4103/0301-4738.176025
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To provide a detailed analysis of age-related macular degeneration (AMD) with a 5-year follow-up at a Tertiary Eye Care Center in India. Methods: In this retrospective institutional study, 408 eyes of 204 subjects (100 males) with a diagnosis of AMD with minimum 5-year follow-up were included. Data collected included demographics, details of the ocular exam, special investigations performed, treatment offered, complications, and systemic diseases, if any. Results: The median age was 74.24 +/- 8.23 years. Median follow-up was 5.77 years. The visual acuity (VA) at baseline and last visit was 0.74 +/- 0.12 (Snellen's equivalent 20/100) and 0.54 +/- 0.12 logarithm of the minimum angle of resolution (Snellen's equivalent 20/50; P = 0.032) in patients with choroidal neovascular membrane (CNVM). The most common complaint was decreased vision (94.5%). AMD (any stage) was found to be bilateral in 93% of patients at baseline and 197 patients (96.56%) at 5 years. Seventeen eyes had active CNVM (12 of these were occult) at presentation. At baseline, 43 eyes had a disciform scar. Three hundred twenty-one eyes had dry AMD at baseline (geographic atrophy - 12 [3.7%] eyes). Five-year conversion rate into wet AMD and geographic atrophy was 2.87% and 3.12%. Median number of anti-vascular endothelial growth factor injections administered per patient was 2.8 +/- 1.2. CNVM bilaterality was low (7.5%). Conclusion: Patients with AMD in India presented later in the course of the disease. Bilateral advanced AMD and geographic atrophy were uncommon. Five-year conversion rate into wet AMD and geographic atrophy was 2.87% and 3.12%.
引用
收藏
页码:899 / 904
页数:6
相关论文
共 50 条
  • [31] Differential age-related changes in the regional metencephalic volumes in humans: a 5-year follow-up
    Raz, N
    Rodrigue, KM
    Kennedy, KM
    Dahle, C
    Head, D
    Acker, JD
    NEUROSCIENCE LETTERS, 2003, 349 (03) : 163 - 166
  • [32] Fluorescence lifetime imaging ophthalmoscopy (FLIO) follow-up analysis in patients with age-related macular degeneration
    Buxton, Jace
    Sauer, Lydia
    Vitale, Alexandra S.
    Modersitzki, Natalie K.
    Bernstein, Paul S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [33] Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration
    Jonas, J. B.
    Spandau, U. H.
    Kamppeter, B. A.
    Harder, B.
    EYE, 2007, 21 (03) : 387 - 394
  • [34] Ranibizumab (Lucentis) in neovascular age-related macular degeneration (AMD): five year follow up
    Cvetkova, Nadezhda
    Maerker, David
    Helbig, Horst
    Hoelldobler, Kristina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [35] TEN-YEAR FOLLOW-UP OF FELLOW EYES IN PATIENTS WITH UNILATERAL NAIVE EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Giuffrida, Francesco Pozzo
    Nassisi, Marco
    de Sanctis, Lorenzo
    Milella, Paolo
    Malerba, Alessia
    Mapelli, Chiara
    Dell'Arti, Laura
    Casaluci, Marco
    Romano, Francesco
    Invernizzi, Alessandro
    Staurenghi, Giovanni
    Viola, Francesco
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (12): : 2049 - 2056
  • [36] Treatment of Exudative Age-Related Macular Degeneration with Intravitreal Ranibizumab in Clinical Practice: A 3-Year Follow-Up
    Marques, Ines R.
    Fonseca, Pedro
    Cachulo, M. Luz
    Pires, Isabel
    Figueira, Joao
    de Abreu, J. R. Faria
    Silva, Rufino
    OPHTHALMOLOGICA, 2013, 229 (03) : 158 - 167
  • [37] Aflibercept in Refractory Wet Age-Related Macular Degeneration: Anatomical and Functional Outcomes After One Year of Follow-Up
    Castro, Veronica
    Montero, Javier
    Cervera, Enrique
    OPHTHALMOLOGICA, 2014, 232 : 2 - 3
  • [38] Pharmacogenetic Aspect of Intravitreal Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Five-Year Follow-Up
    Sengul, Elvan Alper
    Artunay, Ozgur
    Rasier, Rifat
    Kockar, Alev
    Afacan, Ceyda
    Hancer, Veysel Sabri
    Yuzbasioglu, Erdal
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (06) : 971 - 977
  • [39] Increased fall risk in patients with neovascular age-related macular degeneration: a three-year follow-up study
    Chung, Shiu-Dong
    Hu, Chao-Chien
    Lin, Herng-Ching
    Kao, Li-Ting
    Huang, Chung-Chien
    ACTA OPHTHALMOLOGICA, 2017, 95 (08) : e800 - e801
  • [40] Refractive error and smoking habits in exudative age-related macular degeneration in a hospital-based setting
    Tao, Y.
    Jonas, J. B.
    EYE, 2010, 24 (04) : 648 - 652